Contents
-
What Causes CML?
-
Symptoms and Diagnosis
-
Stages of CML
Chronic Myeloid Leukemia: What You Need to Know About This Blood Cancer
Chronic Myeloid Leukemia: What You Need to Know About This Blood Cancer
The Big Picture
Chronic Myeloid Leukemia (CML) is a type of blood cancer that affects the production of white blood cells. It's caused by a genetic change that creates an abnormal protein, leading to uncontrolled cell growth.
Contents
-
What Causes CML?
-
Symptoms and Diagnosis
-
Stages of CML
What Causes CML?
CML is caused by a genetic change called the Philadelphia chromosome. This occurs when parts of chromosomes 9 and 22 swap places, creating an abnormal gene called BCR-ABL1. This gene produces a protein that signals cells to grow and divide uncontrollably, leading to an overproduction of immature white blood cells.
Symptoms and Diagnosis
Many people with CML don't have symptoms at first and are diagnosed through routine blood tests. When symptoms do occur, they can include fatigue, weight loss, night sweats, and abdominal discomfort from an enlarged spleen. Doctors diagnose CML through blood tests, bone marrow biopsies, and genetic tests that look for the Philadelphia chromosome or BCR-ABL1 gene.
Stages of CML
CML progresses through three phases: chronic, accelerated, and blast crisis. Most people are diagnosed in the chronic phase, which is the least severe. The accelerated phase shows more immature cells in the blood and bone marrow. Blast crisis is the most severe phase and resembles acute leukemia.
FAQs
Is CML curable?
While not typically curable, CML is highly treatable with targeted therapies.
Who is at risk for CML?
CML can affect anyone, but it's more common in older adults and slightly more frequent in men.
How is CML treated?
CML is primarily treated with targeted drugs called tyrosine kinase inhibitors (TKIs).
Can CML be prevented?
There's no known way to prevent CML, as its cause is largely unknown.
Living with CML
With modern treatments, many people with CML can lead normal lives and have a life expectancy similar to the general population.
Additional References
-
Faderl S, Talpaz M, Estrov Z, et al. The biology of chronic myeloid leukemia. N Engl J Med 1999; 341:164.
-
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127:2391.
-
Bower H, Björkholm M, Dickman PW, et al. Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. J Clin Oncol 2016; 34:2851.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.